High-dose chemotherapy in relapsed Hodgkin's lymphoma patients

被引：0
|
作者：
Belyaeva, E. [1 ]
Dolgopolov, I. [1 ]
Popa, A. [1 ]
Boyarshinov, V. [1 ]
Pimenov, R. [1 ]
Morozova, O. [1 ]
Visochin, I. [1 ]
Mentkevich, G. [1 ]
机构：
[1] Inst Ped Oncol Hematol, Moscow, Russia
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S440 / S440
页数：1
相关论文
共 50 条
  • [41] Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma -: Results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).
    Josting, A
    Rudolph, C
    Mapara, M
    Glossmann, JP
    Sieber, M
    Kirchner, HH
    Dörken, B
    Hossfeld, DK
    Kisro, J
    Metzner, B
    Berdel, WE
    Diehl, V
    Engert, A
    BLOOD, 2004, 104 (11) : 92A - 92A
  • [42] The cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma
    Beard, SM
    Lorigan, PC
    Sampson, FC
    BRITISH JOURNAL OF CANCER, 2000, 82 (01) : 81 - 84
  • [43] Tandem myeloablative 131I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients
    Deshayes, Emmanuel
    Kraeber-Bodere, Francoise
    Vuillez, Jean-Philippe
    Bardies, Manuel
    Teulon, Isabelle
    Pouget, Jean-Pierre
    IMMUNOTHERAPY, 2013, 5 (12) : 1283 - 1286
  • [44] High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)
    Oyan, B
    Koc, Y
    Ozdemir, E
    Kansu, E
    BLOOD, 2004, 104 (11) : 393B - 393B
  • [45] The high-dose sequential (HDS) chemotherapy regimen as salvage treatment in 110 refractory/relapsed Hodgkin's Lymphoma patients: A multicentre, retrospective evaluation of the Italian Lymphoma Intergroup.
    Tarella, C
    Cuttica, A
    Vitolo, U
    Liberati, M
    Di Nicola, M
    Cortelazzo, S
    Coser, P
    Di Renzo, N
    Musso, M
    Pavone, E
    Santini, G
    Pescarolo, A
    De Crescenzo, A
    Federico, M
    Gallamini, A
    Boccomini, C
    Romano, R
    Rosanelli, C
    Gallo, E
    Barbui, T
    Gianni, AM
    Pileri, A
    Levis, A
    BLOOD, 2001, 98 (11) : 862A - 862A
  • [46] High-dose chemotherapy in lymphoma
    Schmitz, N
    Taghipour, G
    Ruiz, C
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S304 - S304
  • [47] High-Dose Cyclophosphamide (Cy), Rituximab, and a Cancer Vaccine for Relapsed Classical Hodgkin's Lymphoma (cHL)
    Kasamon, Yvette. L.
    Jones, Richard J.
    Levitsky, Hyam I.
    Borrello, Ivan. M.
    Lemas, M. Victor
    Borowitz, Michael J.
    Bolanos-Meade, Javier
    Swinnen, Lode J.
    Ambinder, Richard F.
    BLOOD, 2010, 116 (21) : 1612 - 1613
  • [48] Erythropoietin is effective in patients with relapsed lymphoma treated with the Cologne high-dose sequential chemotherapy regimen
    Glossmann, J
    Engert, A
    Wassmer, G
    Fiechtner, H
    Ko, Y
    Rudolph, C
    Llliger, J
    Dörken, B
    Wiedenmann, S
    Diehl, V
    Josting, A
    BONE MARROW TRANSPLANTATION, 2002, 29 : S92 - S92
  • [49] Short high-dose CHOP chemotherapy for aggressive non-Hodgkin's lymphoma (NHL).
    Epelbaum, R
    Dann, E
    Drumea, K
    Haim, N
    Ben-Shahar, M
    Faraggi, D
    Rowe, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 584S - 584S
  • [50] Combining yttrium 90-labeled ibritumomab tiuxetan with high-dose chemotherapy and stem cell support in patients with relapsed non-Hodgkin's lymphoma
    Winter, JN
    CLINICAL LYMPHOMA, 2004, 5 : S22 - S26
12345